Literature DB >> 9592211

[The effects of Leprosy on men and women: a gender study]

.   

Abstract

On the basis of social representations, we detected gender differences in family and individual living experiences for people with Hansen's disease (HD, or leprosy) in a sample of 202 HD patients (132 men and 70 women) enrolled in a public treatment and control program in Ribeirão Preto, São Paulo State. Information was gathered in two stages. First, the HD patients responded to a structured questionnaire, and second, the authors heard reports from 10 men and 10 women on their daily living situations. Data indicated that the disease receives different representations by men as compared to women in the different social groups. HD was found to be a source of gender imbalance, further aggravating existing sociocultural inequalities and creating new sources of biopsychosocial and economic harm, in addition to the stigmata weighing on individual patients. Results should help reorient treatment and control programs aimed at the social rehabilitation of HD patients, besides serving as a paradigm for future research

Entities:  

Year:  1998        PMID: 9592211     DOI: 10.1590/s0102-311x1998000100013

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  7 in total

1.  Limitation of activity and restriction of social participation in relation to age range, gender, and education in people with leprosy.

Authors:  Bianca Manzan Reis; Shamyr Sulyvan de Castro; Luciane Fernanda Rodrigues Martinho Fernandes
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

2.  Spatial clustering and local risk of leprosy in São Paulo, Brazil.

Authors:  Antônio Carlos Vieira Ramos; Mellina Yamamura; Luiz Henrique Arroyo; Marcela Paschoal Popolin; Francisco Chiaravalloti Neto; Pedro Fredemir Palha; Severina Alice da Costa Uchoa; Flávia Meneguetti Pieri; Ione Carvalho Pinto; Regina Célia Fiorati; Ana Angélica Rêgo de Queiroz; Aylana de Souza Belchior; Danielle Talita Dos Santos; Maria Concebida da Cunha Garcia; Juliane de Almeida Crispim; Luana Seles Alves; Thaís Zamboni Berra; Ricardo Alexandre Arcêncio
Journal:  PLoS Negl Trop Dis       Date:  2017-02-27

3.  Status and forecast of leprosy in the still endemic province of Formosa in northern Argentina.

Authors:  María R Arnaiz; Mónica S Iglesias; José I Franco; Lucila Arzamendia; María S Santini; Hugo C Recalde
Journal:  PLoS Negl Trop Dis       Date:  2021-01-05

4.  Inequality of gender, age and disabilities due to leprosy and trends in a hyperendemic metropolis: Evidence from an eleven-year time series study in Central-West Brazil.

Authors:  José Francisco Martoreli Júnior; Antônio Carlos Vieira Ramos; Josilene Dalia Alves; Juliane de Almeida Crispim; Luana Seles Alves; Thaís Zamboni Berra; Tatiana Pestana Barbosa; Fernanda Bruzadelli Paulino da Costa; Yan Mathias Alves; Márcio Souza Dos Santos; Dulce Gomes; Mellina Yamamura; Ione Carvalho Pinto; Miguel Angel Fuentealba-Torres; Carla Nunes; Flavia Meneguetti Pieri; Marcos Augusto Moraes Arcoverde; Felipe Lima Dos Santos; Ricardo Alexandre Arcêncio
Journal:  PLoS Negl Trop Dis       Date:  2021-11-16

Review 5.  A Literature Review: The History of Psychological Impact of Illness amongst People with Leprosy (PwL) in Countries across the Globe.

Authors:  Pati Aji Achdiat; Eko Fuji Ariyanto; Michael Nobel Simanjuntak
Journal:  Dermatol Res Pract       Date:  2021-11-09

Review 6.  Factors preventing early case detection for women affected by leprosy: a review of the literature.

Authors:  Victoria Grace Price
Journal:  Glob Health Action       Date:  2017 Jan - Dec       Impact factor: 2.640

7.  Leprosy and gender in Brazil: trends in an endemic area of the Northeast region, 2001-2014.

Authors:  Eliana Amorim de Souza; Anderson Fuentes Ferreira; Reagan Nzundu Boigny; Carlos Henrique Alencar; Jorg Heukelbach; Francisco Rogerlândio Martins-Melo; Jaqueline Caracas Barbosa; Alberto Novaes Ramos
Journal:  Rev Saude Publica       Date:  2018-02-26       Impact factor: 2.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.